LET's cut to the chase: the current test of wills and wiles between President Rodrigo Duterte and the Senate blue ribbon committee investigating the P8.6 billion in health contracts bagged by the Pharmally Pharmaceutical Corp., along with other pandemic response issues, could derail the one indispensable piece of legislation for the lives and livelihoods of Filipinos at this difficult and deadly time - the national budget for 2022.

If the acrimony between Palace and Senate leads legislators to again get delayed in passing the General Appropriations Act (GAA) for next year, as they were in 2019, then the adverse economic and social consequences for the nation would be immense.

Premium + Digital Edition

Ad-free access


P 80 per month
(billed annually at P 960)
  • Unlimited ad-free access to website articles
  • Limited offer: Subscribe today and get digital edition access for free (accessible with up to 3 devices)

TRY FREE FOR 14 DAYS
See details
See details